ABT Q1 2015 report - in Norwegian ABT Q1 2015 press release ABT Q1 2015 presentationAqua Bio Technology ASA (Oslo Axess: ABT) today announced the first quarter 2015 financial results. The Company's profitability improved significantly, and the quarterly result was the second best in the Company's history.
Aqua Bio Technology had revenues of NOK 9.1 million in the first quarter of the year, which is an increase from last year's NOK 5.4 million. The first quarter revenues consist mainly of license and royalty payments from exclusivity partners.
The Company's EBITDA improved significantly, from NOK 1.2 million in last year's first quarter to NOK 5.2 million in the first quarter of 2015. The result corresponds to an EBITDA margin of 57.7 per cent. ABT's net result for the first quarter came in at NOK 4.1 million, compared to NOK -0.4 million last year.
"ABT's strong financial position and profitability last year enabled the Board to propose for the General Assembly a NOK 1.00 per share dividend payment for 2014, the first in the Company's history"said CEO Arvid Lindberg. "The first quarter 2015 results are also satisfactory and in line with our expectations", he continued.
The Company's first quarter revenues reflect ABT's contracts with two exclusivity partners in the cosmetics industry. The revenue stream from these contracts will continue in 2015 and 2016.
Aqua Bio Technology is also exploring opportunities to expand its business. The Company's strategy is to grow through in-licensing of third party technologies. ABT is also considering venturing into the development of new ingredients for medical purposes.
For further information, please call Arvid Lindberg, CEO, telephone +47 9824 5410
Aqua Bio Technology (ABT) has launched cosmetic ingredients used in skin care products globally. The ingredients, based on the Company's unique, marine technology and other technologies, have documented positive effects on the skin. Skin care is the fastest growing segment in the cosmetics industry, where ABT's ingredients have established a foothold. In addition to ingredients from its own technology, ABT also commercializes technologies/ingredients for partners. Aqua Bio Technology is listed on the the Oslo Stock Exchange, Oslo Axess (ticker: abt.oax)